Market Research Blog – Page 873 – New Product Development

Genomics Market is expected to grow USD 170.5 Billion at a CAGR of 23% from 2022 to 2032

According to Future Market Insights’ newly released Genomics industry analysis report, According to Future Market Insights’ recently published analysis of the genomics market, global sales of genomics were estimated to reach USD 24.3 billion in 2021. The anticipated market growth from 2022 to 2032 is anticipated to be 19.8%, which will be much larger than the increase in the past. The greatest revenue-generating kind, functional genomics, is anticipated to rise at a CAGR of 23% from 2022 to 2032.

Crucial information and forecast statistics covered in the Genomics market report will arm both existing and emerging market players with necessary insights to craft long-term strategies.

Following government’s measures, particularly social distancing norms and stay-at-home orders, doctors are delaying or postponing elective surgeries unless critical to prevent the spread of the virus to individuals with comorbidities or chronic conditions. Additionally, movement restrictions and supply chain disruptions have created a logistical nightmare for market players, leading to severe product shortages in the global marketplace.

The FMI’s report includes an interesting chapter on preliminary impact of the COVID-19 on the Genomics market. This allows both leading and emerging market players to understand the market scenario during a crisis and aids them in making sound decisions to gain a distinct competitive edge.

A Full Report Overview

Genomics Market: Segmentation

Valuable information covered in the FMI’s Genomics market report has been segregated into key segments and sub-segments.

By Application:

Functional Genomics
- Real-time PCR
- Transfection
- SNP Analysis
- Mutational Analysis
- Microarray Analysis
- RNA Interference
Pathway Analysis
- Microarray Analysis
- Bead-based Analysis
- Proteomics Tools
- Real-time PCR
- Mass Spectrometry
Biomarker Discovery
- DNA Sequencing
- Microarray Analysis
- Real-time PCR
- Mass Spectrometry
- Other Biomarker Discoveries
Epigenetics
- Bisulfite Sequencing
- Microarray Analysis
- Chromatin Immunoprecipitation
- Methylated DNA Immunoprecipitation
- Other Epigenetics

Other Application & Technologies

By Deliverable:

Products
Services

By End-use:

Pharmaceutical and Biotechnology Companies
Hospitals and Clinics
Academic and Government Institutes
Clinical Research
Other End Users

Genomics Market: Competition Analysis

The FMI’s study presents a comprehensive analysis of global, regional, and country-level players active in the Genomics market. Competitive information detailed in the Genomics market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Genomics market report.

Key players covered in the report include:

Thermo Fisher Scientific, Agilent Technologies, Beijing Genomics Institute, Bio-Rad Laboratories, Danaher Corporation, F. Hoffmann-La Roche Ltd., GE Healthcare, Illumina Inc., Oxford Nanopore Technologies, QIAGEN N.V., Myriad Genetics, Inc., Quest Diagnostics Incorporated, Eppendorf AG, and Eurofins Scientific

Key Offerings of the Report

Growth Drivers and Opportunities: Comprehensive analysis on growth-driving factors and opportunities for market players in different regional markets
Recent Trends and Forecasts: Detailed assessment on the latest trends, technological developments, and forecasts for a 5-year or 10-year period.
Segmental Analysis: Extensive analysis on each segment and factors differentiating the role of these segments in market revenue forecasts and growth rate analysis
Regional Market Forecast: Thorough analysis of each regional market to arm stakeholders with necessary information to take critical decisions
Competitive Landscape: All-inclusive insights on both leading and emerging players vying for a slice of the Genomics market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Treatment-Resistant Depression Treatment Market is expected to expand at a CAGR of 9.0%, to reach a significant USD 4.0 Billion by 2033

There’s promising news for those struggling with Treatment-Resistant Depression Treatment Market for these specialized therapies is projected to reach a significant USD 4.0 billion by 2033, growing at a steady CAGR of 9.0%. This significant rise reflects the increasing prevalence of depression and anxiety disorders in adults, alongside a growing aging population.

FMI, in its upcoming business report, elaborates on the historical and current scenario of the global Treatment-Resistant Depression Treatment Market in terms of production, consumption, volume, and value. The report scrutinizes the market into various segments, regions, and players based on demand patterns and growth prospects.

Crucial information and forecast statistics covered in the Treatment-Resistant Depression Treatment market report will arm both existing and emerging market players with necessary insights to craft long-term strategies as well as maintain business continuity during a crisis such as the ongoing COVID-19 pandemic.

COVID-19 Impact Analysis on Treatment-Resistant Depression Treatment Market

The recent outbreak of COVID-19 has turned the spotlight on the healthcare industry and subsequently impacted the Treatment-Resistant Depression Treatment market. Severe shortages of critical medical supplies and a rapid rise in several COVID-19 cases have resulted in a revolution rather than an evolution in the healthcare ecosystems. Consequently, the impact is noticeable in the Treatment-Resistant Depression Treatment market.

Following government measures, particularly social distancing norms and stay-at-home orders, doctors are delaying or postponing elective surgeries unless critical to prevent the spread of the virus to individuals with comorbidities or chronic conditions. Additionally, movement restrictions and supply chain disruptions have created a logistical nightmare for market players, leading to severe product shortages in the global marketplace.

The FMI’s report includes an interesting chapter on the preliminary impact of COVID-19 on the Treatment-Resistant Depression Treatment market. This allows both leading and emerging market players to understand the market scenario during a crisis and aids them in making sound decisions to gain a distinct competitive edge.

Treatment-Resistant Depression Treatment Market: Segmentation

Valuable information covered in the FMI’s Treatment-Resistant Depression Treatment market report has been segregated into key segments and sub-segments.

Treatment-Resistant Depression Treatment Market by Drug Type:

NMDA
Antidepressants
Antipsychotics
Others

Treatment-Resistant Depression Therapeutics Market by Distribution Channel:

Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies

Treatment-Resistant Depression Treatment Market: Competition Analysis

The FMI’s study presents a comprehensive analysis of global, regional, and country-level players active in the Treatment-Resistant Depression Treatment market. Competitive information detailed in the Treatment-Resistant Depression Treatment market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Treatment-Resistant Depression Treatment market report.

Key players covered in the report include:

Eli Lilly and Company
GlaxoSmithKline
Pfizer Inc.
Janssen Pharmaceuticals
AbbVie Inc.
AstraZeneca
H. Lundbeck A/S
Sandoz International GmbH
Par Pharmaceutical Companies Inc.
Otsuka Holdings Co., Ltd.

A Full Report Overview

Important Questions Answered in the Treatment-Resistant Depression Treatment Market Report

Which end-user remains the top revenue contributor in different regional markets?
At what rate has the global Treatment-Resistant Depression Treatment market been expanding during the forecast period?
How will the global Treatment-Resistant Depression Treatment market look like by the end of the forecast period?
What innovative strategies are adopted by Treatment-Resistant Depression Treatment market players to stay ahead of the pack?
What are the restraints affecting the growth of the global Treatment-Resistant Depression Treatment market?

Key Offerings of the Report

Growth Drivers and Opportunities: Comprehensive analysis on growth-driving factors and opportunities for market players in different regional markets
Recent Trends and Forecasts: Detailed assessment on the latest trends, technological developments, and forecasts for a 5-year or 10-year period.
Segmental Analysis: Extensive analysis on each segment and factors differentiating the role of these segments in market revenue forecasts and growth rate analysis
Regional Market Forecast: Thorough analysis of each regional market to arm stakeholders with the necessary information to make critical decisions
Competitive Landscape: All-inclusive insights on both leading and emerging players vying for a slice of the Treatment-Resistant Depression Treatment market

About Future Market Insights (FMI)

Contact Us:

Bleeding Disorder Testing Market Expected to Grow at a 7.2% CAGR to Reach USD 190 Billion by 2033

The Bleeding Disorder Testing Market is poised for significant growth, with a projected market value of USD 190 billion by 2033. This represents a near-doubling from its current value of USD 95 billion in 2023. This significant expansion is attributed to a 7.2% CAGR (Compound Annual Growth Rate) expected throughout the forecast period.

In the affected body location, a clump of platelets and a specific type of blood cell forms. This clot keeps infections out of the bloodstream and prevents blood from draining from the injured area. Testing for bleeding disorders can help determine whether specific clotting factors are present and how long it takes for blood to clot.

The test measures the time it takes for the arteries to contract and platelets in the blood to close the opening. According to the National Haemophilia Foundation, Von Willebrand disease is the most common bleeding disorder, affecting around one in every 100 people, or up to 1% of the US population.

Bleeding Disorder Testing Market Key Takeaways:

According to FMI, the Global Bleeding Disorder Testing market will grow at a 7.2% CAGR by 2033.
The global bleeding disorder testing industry is predicted to be worth $ 95 billion.
The global bleeding disorder testing industry is anticipated to be worth US$ 190 billion.
North America is expected to be the most profitable market for Bleeding Disorder Testing growth.
According to Future Market Insights, Asia Pacific is predicted to develop at a CAGR of 6.5% from 2023 to 2033.
Europe is predicted to increase at a CAGR of 6.9% between 2023 and 2033.
In the forecast period 2023 to 2033, the diagnostic centers category is estimated to hold the greatest market share for Bleeding Disorder Testing.

“The North American market is expected to expand significantly throughout the projected period. The increase can be attributed to the increased availability of testing devices and the rising number of regulatory approvals,” says an analyst at FMI

Bleeding Disorder Testing Market Growth:

Increasing Blood Disorder Prevalence to Improve Maintenance and Performance

Chronic illness includes blood issues. They are also hazardous since they circulate in the blood. The prevalence of conditions such as liver disease, anaemia, and other blood coagulation concerns has increased, as has the demand for bleeding disorders testing. These inherited diseases resulted in a profitable market expansion.

Government Investments in Healthcare Interoperability Have an Impact on the Market

The increasing funding provided by the federal government to encourage the use of these solutions has an additional impact on the sector. Furthermore, rising healthcare spending, advancements in healthcare infrastructure, and rising need for long-term care delivery all benefit the bleeding disorders testing sector, promoting market expansion.

Bleeding Disorder Testing Market Competition:

Key players

Siemens Healthcare GmbH
F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Thermo Fisher Scientific Inc.
Atlas Medical GmbH
Horiba Ltd.
Hyphen Bio Med
Precision Biologics Incorporated
Pfizer Inc.
Baxter

Bleeding Disorder Testing Market Recent Developments

In March 2021, F. Hoffmann La Roche Ltd. introduced eight new configurations for Cobas Pro integrated solutions, to increase throughput and testing efficiency.

A Full Report Overview

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the Global automotive axle market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.

The study reveals essential insights based on Product Type (Reagents & Consumables and Instruments), Indication (Hemophilia A, Hemophilia B, Von Willebrand Disease, Idiopathic Thrombocytopenic Purpura and Others), (Hospitals & Clinics, Diagnostic Centers and Others), across seven major regions (North America, Latin America, Europe, South Asia & Pacific, East Asia and Middle East & Africa).

About Future Market Insights (FMI)

Contact Us:

Pharmaceutical Dissolution Testing Services Market is expected to reach USD 1.53 Billion at a CAGR of 8.3% by 2033

The Pharmaceutical Dissolution Testing Services Market is poised for significant growth, with a projected market value of USD 1.53 billion by 2033. This surge represents a substantial increase from the USD 693.12 million market value in 2023, reflecting a robust Compound Annual Growth Rate (CAGR) of 8.3%.

For the physical assessment of solid dosage forms, such as tablets, capsules, ointments, and creams, dissolution testing is required. The simplest type of testing measures the solubility or rate of dissolving a medication tablet. Dissolution testing can be performed to assess the release rates of a drug material under various situations and to provide details regarding the effectiveness of in vivo performance in Absorption, Distribution, Metabolism, And Excretion (ADME) and bioavailability studies.

Dissolution testing provides information on how quickly or slowly certain drugs are absorbed into various body parts and, subsequently, how much they dissolve after administration. This enables businesses to assess whether a drug will function effectively after it enters a patient’s system and whether any negative effects brought on by slower absorption rates would occur.

Key Takeaways from the Pharmaceutical Dissolution Testing Services Market Study

By dosage form, the tablets dosage form segment is expected to dominate the global industry in 2023 and account for the maximum share of more than 65% of the overall revenue.
By dissolution apparatus, the paddle segment is expected to dominate the industry and account for the largest revenue share of more than 70% in 2023.
By method, the in-vitro method segment is expected to dominate the global market in 2023 and account for the largest share of more than 58% of the overall revenue.
North America is expected to dominate the global industry in 2023 and account for the maximum share of more than 50% of the overall revenue.
Asia Pacific is expected to possess 33% market share for pharmaceutical dissolution testing services market in Asia Pacific.

“Pharmaceutical dissolution testing requires specialized staff to run the assays and prepare regulatory filings. This factor has greatly increased the demand for professional teams to handle pharmaceutical dissolution testing, which is predicted to have a favorable effect on the industry.” comments a Future Market Insights analyst.

Pharmaceutical Dissolution Testing Services Market Competitive Landscape

Some of the prominent players in the global pharmaceutical dissolution testing services market include Intertek Group Plc, Avivia BV, Almac Group, Agilent Technologies, Inc, Catalent, Inc, Thermofisher Scientific Inc, Cambrex, Charles River Laboratories, Boston Analytical, Pace Analytical Life Sciences, SOTAX, AMRI, SGS SA

In August 2022, Almac, AstraZeneca CDx have entered into a partnership that is branching out to new disease areas, drawing on NGS, qPCR. The company is focusing on investing in research and development to assess and understand nature of diseases and manufacture medication for the same.
Avivia, a key player in pharmaceutical dissolution testing services market is focusing on offering full product development services to generic drug companies and specialty pharma focused on the development of new improved versions (value-added generics or generic plus) of established drug products.

A Full Report Overview

Drug Dissolution Analysis is a critical aspect of drug development and manufacturing, which involves the assessment of the rate at which a drug substance dissolves in a specific medium.

Key Segments Profiled in the Pharmaceutical Dissolution Testing Services Market Survey

By Method:

In Vitro
In Vivo

By Dosage Form:

Capsules
Tablets
Others

By Dissolution Apparatus:

Basket
Paddle
Others

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Arterial Cannula Market to Expand Rapidly, Reaching USD 40 Billion at a Consistent 6.6% CAGR by 2033

The Arterial Cannula Market is experiencing a significant surge, driven by their crucial role in heart surgeries and interventions. According to a recent report, the market reached a value of USD 21 billion in 2023 and is projected to reach a staggering USD 40 billion by 2033, reflecting a healthy Compound Annual Growth Rate (CAGR) of 6.6%.

Arterial cannulae play a crucial role during cardiopulmonary bypass (CPB) procedures, facilitating perfusion into the ascending aorta. These essential medical devices come in a variety of materials, including biocompatible materials, silicone, polyurethane, polyvinyl chloride (PVC), and more. Their flexibility, translucency, and feature of hard or smooth plastic tips, along with secure connections, typically characterize arterial cannulas. The tip of a cannula may have a straight or curved design, often equipped with a vent plug for efficient de-airing during cannulation. Some advanced cannulas also incorporate wire reinforcement to enhance durability, reduce the risk of kinking, and optimize wall thickness.

The increased incidence of lifestyle disorders like obesity and diabetes is increasing the number of surgical procedures performed throughout the world. This is a significant factor that is expected to improve arterial cannula market sales. Moreover, the growing ageing population and rising demand for minimally invasive procedures (MIS) are likely to propel market growth. The worldwide arterial cannula market is predicted to increase at an exponential rate during the forecast period, owing primarily to the rising prevalence of cardiovascular illnesses. According to the American Heart Association, approximately half of all individuals in the United States had some kind of cardiovascular disease in 2019. Furthermore, according to the CDC, around 20.1 million persons aged 20 and older in the United States had coronary artery disease in 2020, accounting for approximately 7.2% of the overall population.

Furthermore, the rising popularity of aesthetic operations, as well as the expanding influence of social media, is driving up demand for arterial cannulas. In Addition to that, good government laws for delivering essential healthcare services, as well as advances in healthcare facilities are expected to drive the worldwide arterial cannula market. Furthermore, important suppliers are investing in R&D projects in order to create high-quality items.

Key Takeaways from the Arterial Cannula Market Study

FMI projects the global arterial cannula market to expand at a 6.6% value CAGR by 2033
The global arterial cannula market is estimated at a market value of US$ 21 Billion
The global arterial cannula market is expected to garner a market value of US$ 40 Billion
North America is expected to be the most lucrative for arterial cannula market growth
As per Future Market Insights, the Asia Pacific is expected to grow at a CAGR of 6.1% in the assessment period 2023-2033.
As per Future Market Insights, the Europe is expected to grow at a CAGR of 6.3% in the assessment period 2023-2033.
The hospitals segment is expected to hold the largest market share for arterial cannula in the forecast period 2023-2033.

“Asian countries with large ageing populations, such as Japan, China, and India, promises significant development potential for the sector in this area,” says an analyst at FMI

Arterial Cannula Market Competition:

Medtronic, plc.
LivaNova plc
Edward Lifesciences
Getinge AB
Fresenius Medical Care
BD, Nipro Corp.
Andocor
Freelife Medical GmbH
Surgical Holdings
Kangxin Medical.

Arterial Cannula Market Recent Developments:

In April 2020, LivaNova Plc. got a CE mark for their Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula for ECMO treatments in which femoral artery cannulation can be used.

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the global Arterial Cannula market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023-2033.

The study reveals essential insights based on Application (ECMO, Cardiopulmonary Bypass Surgery), by Size (20-22 Fr, 35-36 Fr), by End-use (Hospitals, ASCs), across five major regions (North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa).

About the Healthcare Division at Future Market Insights

The healthcare team at Future Market Insights offers expert analysis, time efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis on key trends including competitive landscape, profit margin, and research development efforts.

A Full Report Overview

Key Segments Profiled in the Arterial Cannula Market Industry Survey

Arterial Cannula Market by Application:

Extracorporeal Membrane Oxygenation (ECMO)
Cardiopulmonary Bypass Surgery
Others

Arterial Cannula Market by Size:

14-16 Fr
17-19 Fr
20-22 Fr
23-25 Fr
26-28 Fr
29-31 Fr
32-34 Fr
35-36 Fr

Arterial Cannula Market by End Use:

Hospitals
Ambulatory Surgical Centers
Others

About Future Market Insights (FMI)

Contact Us:

3D Printed Prosthetics Market is expected to be worth USD 3.5 Billion, growing at a rate of 8% annually By 2033

The future of prosthetics is taking shape, and its 3D Printed Prosthetics Market is expected to surge in value, reaching an estimated USD 3.5 billion by 2033. That’s a significant jump from its current market value of USD 1.62 billion in 2023, reflecting a robust Compound Annual Growth Rate (CAGR) of 8%.

The World Health Organization estimates that around 30 million globally need prosthetics, and adopting the 3D printing technique can help increase availability for individuals, especially in remote regions at a lower cost. Such factors coupled with high patient comfort and easy customization are expected to boost the market growth. Advancements in body modeling and 3D scanning technologies from players such as Body Labs will enable individuals to 3D scan their limbs and have prosthetics molded after them, allowing a more natural fitting and appearance.

The advent of COVID-19 impacted the additive manufacturing market as the pandemic resulted in supply chain bottlenecks and manufacturing closures mostly in the initial quarters of 2020. However, the 3D printing market witnessed a significant boost post-pandemic as this is a disruptive technology and has emerged as a potential solution to curb medical device supply shortages. Moreover, the key players in the 3D printed prosthetics market reported a sales increase in 2021 and this indicates that the market has recovered from the COVID-19 impact and is expected to grow eminently in the future.

Key Takeaways from the 3D Printed Prosthetics Market Study

By type, the limbs segment is expected to dominate the global market for 3D printed prosthetics and account for 35% of the overall revenue share.
By end use, the hospitals segment is expected to account for the maximum share of 40% of the overall revenue in 2023.
By material, the polypropylene segment is expected to dominate the global market in 2023 and account for the largest revenue share of 33%.
North America is expected to dominate the global market in 2023 and account for more than 40% of the global revenue share in the same year.
Asia Pacific is expected to possess 37% market share for 3D printed prosthetics market in 2023.

“Increasing cases of accidental and sports injures is the key factor driving the growth of the 3D printed prosthetics market. In addition, technological advancement too is spurring the adoption of 3D printed prosthetics,” comments a Future Market Insights analyst.

3D Printed Prosthetics Market Competitive Landscape

Some of the players in the global 3D printed prosthetics market include 3D Systems Corporation, EnvisionTEC, Stratasys Ltd., Bionicohand, YouBionic, UNYQ, Mecuris, LimbForge, Inc., Open Bionics, Create Prosthetics, Bio3D Technologies, Laser GmbH, Prodways Group, Protosthetics, 3T RPD Ltd, Formlabs

YouBionic, a key player in the 3D printed prosthetics is focusing on making their 3D printed prosthetic hand durable, flexible and more movable. Thus, the company is integrating artificial intelligence to increase its usability.
Prodways Group, another key player in the 3D printed prosthetics market offers a technologically advanced arm for patients of all age groups. The company is focusing on offering the same to a wider consumer base by penetrating into different geographical locations.

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global 3D printed prosthetics market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.

A Full Report Overview

Key Segments Profiled in the 3D Printed Prosthetics Market Survey

Type:

Sockets
Limbs
Joints
Others

Material:

Polyethylene
Polypropylene
Acrylics
Polyurethane

End-use:

Hospitals
Rehabilitation Centers
Prosthetic Clinics

About the Healthcare at Future Market Insights

The healthcare domain team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts.

About Future Market Insights (FMI)

Contact Us:

Heart Closure Devices Market is expected to be valued at USD10.88 Billion, growing at a CAGR of 14.9% By 2033

The Heart Closure Devices Market is experiencing a strong pulse, driven by rising demand for minimally invasive procedures. According to a recent analysis, the global Heart Closure Devices Market is expected to reach a staggering USD 10.88 billion by 2033. This represents a significant leap from its estimated value of USD 2.71 billion in 2023, reflecting a robust Compound Annual Growth Rate (CAGR) of 14.9%.

Factors such as an increase in the incidence of congenital heart defects, technological advancements in heart closure devices, a rise in the adoption of MRI procedures, and an upsurge in the geriatric population are expected to augment the growth of the global heart closure devices market over the analysis period.

On the other hand, the high cost of production and stringent regulations associated with these devices limit the market growth. Whereas, an increase in several heart strokes and the development of innovative products by key players are expected to provide lucrative avenues for market expansion in the forthcoming years.

Furthermore, the utilization of 3D imaging and anatomical models in the manufacturing and planning processes of heart closure devices is gaining prominence in the market. This is expected to change the supply landscape of the industry, attributed to characteristics such as personalization, adaptability, and flexibility provided by using 3D imaging technology.

This in turn decreases the overall prostheses employed per patient along with the procedure time, which makes it a viable option in the production and planning process. Similarly, continuous new product launches as well as approvals along with rapid expansion of the healthcare industry across emerging economies will bode well for the market growth shortly.

Heart Closure Devices Market Key Takeaways:

The global heart closure devices market was valued at US$ 2.36 Billion by 2022-end
From 2018 to 2022, the market demand expanded at a CAGR of 6.6%
By Closure Type, the left atrial appendage closure segment of the market constitutes the bulk of the market with a market share of 49%
By End-User, the Hospitals segment dominates the market with a share of 47%
From 2023 to 2033, Heart Closure Devices sales are expected to flourish at a CAGR of 14.9%.
By 2033, the market value of Heart Closure Devices is expected to reach US$ 10.88 Billion

“The rise in patient pool globally, and growing awareness about heart diseases positively are the major factors driving the growth of the Heart Closure Devices Market during the forecast period,” remarks an FMI analyst.

Heart Closure Devices Market Competitive Landscape

Players in the global Heart Closure Devices Market focus on expanding their global reach through various strategies, such as; partnerships, collaborations, and partnerships. The players are also making a significant investment in R&D to add innovations to their products which would help them in strengthening their position in the global market. Some of the recent developments among the key players are:

In July 2021, Angel Medical Systems, Inc. announced the first commercial implantation of their flagship product, “The Guardian” device in the U.S. region. This was the first procedure followed by their recent FDA approval.
In April 2021, Phoenix Cardiac Devices, Inc. announced that they received a CE Mark for their product, BACE (Basal Annuloplasty of the Cardio externally) device. This approval helps in the commercialization of BACE in the European Union.
In March 2021, the U.S. FDA announced the approval of the world’s first non-surgical heart valve treatment for pediatric and adult patients suffering from a native or surgically repaired right Ventricular outflow tract (RVOT). The device was specifically developed to treat patients with severe pulmonary heart regurgitation.

Know More About What the Heart Closure Devices Market Report Covers

Future Market Insights offers an unbiased analysis of the global Heart Closure Devices Market, providing historical data for 2018-2022 and forecast statistics from 2023-2033.

To understand opportunities in the Heart Closure Devices Market, the market is segmented based on closure type across five major regions.

A Full Report Overview

Key Segments:

Heart Closure Devices Market by Closure Type:

Congenital Heart Defect Closure
- Atrial Septal Defect (ASD)
- Patent Ductus Arteriosus (PDA)
- Ventricular Septal Defect (VSD)
Patent Foramen Ovale (PFO) Closure
Left Atrial Appendage (LAA) Closure

Heart Closure Devices Market by Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

About Future Market Insights (FMI)

Contact Us:

Healthcare Companion Robots Market is projected to develop at an astounding 18% CAGR and reach USD11.73 Billion By 2033

The future of healthcare is getting a friendly face! The Healthcare Companion Robots Market is on track for a significant surge, with a projected value of USD 11.73 billion by 2033. This translates to a remarkable 18% CAGR (Compound Annual Growth Rate) from 2023. This significant leap builds upon a solid foundation. The market for healthcare companion robots already experienced a steady 10% CAGR from 2018 to 2022.

With the increasing geriatric population and rising prevalence of diseases such as Alzheimer’s; dementia, etc., the demand for companion robots is likely to increase over a forecast period. Various robots are being developed which help people suffering from such disorders to live a normal life. For instance, Ryan, a companion robot outfitted with artificial intelligence technology is designed to assist the aging population, specifically those struggling with Alzheimer’s. Also, it is equipped with cognitive games to keep the brain active and helps recognize who it interacts with and carry-on conversations. In addition, the increasing incidences of depression is fueling market growth.

Furthermore, with the outbreak of COVID-19, the prevalence of loneliness rose, which positively impacted the demand for companion robots. Paro, a companion robot approved by the FDA as an insured cost for patients is used to assist people with depression, anxiety, and other conditions. These robo-seals are provided in free-to-licensed nursing homes and around 28 nursing homes in Washington State have started using them since last year.

In addition, various initiatives undertaken by market players to provide innovative solutions are anticipated to drive the growth of the market during the forecast period. Furthermore, the integration of advanced technologies to improve healthcare outcomes is expected to boost the market in upcoming years.

Key Takeaways from the Healthcare Companion Robots Market Study

In 2023, Asia Pacific is expected to dominate the healthcare companion robots market with a share of 50%.
North America is expected to possess a 41% market share in the healthcare companion robots market in 2023.
By type, the humanoid segment is expected to hold the largest share of nearly 75% in 2023.
By age group, the geriatric segment is expected to hold the largest share of 40% in 2023.

“Advancement in technology along with increase in dependency on robots especially by the geriatric and disabled population is favoring growth of the healthcare companion robots market.” comments a Future Market Insights analyst.

Healthcare Companion Robots Market Competitive Landscape

Some prominent players in the global healthcare companion robots market include Blue Frog Robotics & Buddy ASUS, Intuition Robotics, inGen Dynamics, PARO Robots U.S., Inc, No Isolation, Luvozo, Honda Robotics, Hanson Robotics, Ubtech, Emotix and Jibo

For instance, in March 2022, Intuition Robotics launched ElliQ, a digital care companion. It is designed to help older adults to be more physically active and socially engaged and enable them to have happier, more independent lives.
Intuition Robotics, a key player in the healthcare companion robots market is focusing on innovating robots that help the geriatric population fight loneliness. Thus, the company is researching on required emotional intelligence and integrating the same through artificial intelligence in the robots.

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global healthcare companion robots market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023-2033.

The study reveals essential insights based on type (Animal-like and Humanoid), age group (Children, Adult, Geriatric) and regions (North America, Latin America, Europe, South Asia, East Asia, Oceania, MEA).

A Full Report Overview

Key Segments Profiled in the Healthcare Companion Robots Market Survey

Type:

Animal-like
Humanoid

Age-Group:

Children
Adult
Geriatric

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Backend-as-a-Service Market Poised to Reach US$ 27.01 Billion by 2033, Growing at 24.5% CAGR

The global Backend-as-a-Service (BaaS) Market is set to experience substantial growth over the next decade, driven by the increasing demand for scalable cloud solutions and the rapid expansion of mobile and web applications. The market, currently valued at US$ 3,011.4 million in 2023, is projected to surge to an impressive US$ 27,016.6 million by 2033, reflecting a robust compound annual growth rate (CAGR) of 24.5% during the forecast period.

BaaS solutions enable developers to automate backend services such as data storage, user authentication, push notifications, and server management, significantly reducing the time and complexity of app development. As organizations focus on improving operational efficiency and user experiences, the adoption of BaaS platforms is expected to accelerate across industries, particularly in sectors like retail, e-commerce, healthcare, and finance.

Key Takeaways from the Market Study:

The Backend-as-a-Service Market is anticipated to grow at a CAGR of 24.5% from 2023 to 2033.
The market is expected to reach US$ 27,016.6 million by 2033, driven by increased demand for mobile and web applications.
Scalability, ease of integration, and cost efficiency are key factors driving the adoption of BaaS platforms across industries.
The North American region dominates the market, with a strong presence of tech companies and early adoption of cloud technologies.

Drivers and Opportunities:

The rapid expansion of mobile and web applications, fueled by the proliferation of smartphones and the digitalization of businesses, is one of the primary drivers of the Backend-as-a-Service Market. Organizations are increasingly adopting BaaS platforms to streamline app development processes, reduce infrastructure management burdens, and ensure faster time-to-market for their digital products.

The growing trend toward cloud-based solutions is also contributing to market growth, as businesses seek to reduce operational costs and leverage scalable backend infrastructures. BaaS allows companies to focus on the front-end user experience while outsourcing backend operations to cloud service providers, resulting in greater agility and flexibility.

In addition, the rising adoption of AI, IoT, and machine learning technologies presents significant opportunities for BaaS providers. By integrating backend services with AI and IoT platforms, businesses can create smarter applications with real-time data processing, predictive analytics, and enhanced automation capabilities.

Component Insights:

The Backend-as-a-Service Market is segmented by component into services and software development kits (SDKs). The services segment holds the largest share of the market, as businesses rely on BaaS providers for a wide range of backend functions, including data management, cloud storage, user authentication, and real-time database updates.

SDKs are gaining popularity as they offer developers pre-built tools to integrate backend services into applications more efficiently. These kits help developers connect their apps to cloud infrastructures without building complex server-side logic from scratch. As the market evolves, SDKs will play a critical role in supporting the rapid development of mobile and web applications.

Application Insights:

BaaS solutions are widely used across various industries, with major applications in e-commerce, healthcare, financial services, education, and gaming. The e-commerce sector is a significant contributor to market growth, as businesses increasingly adopt BaaS to provide seamless shopping experiences through enhanced mobile apps, secure payment gateways, and efficient inventory management systems.

In healthcare, BaaS is being utilized to support telemedicine platforms, electronic health records (EHRs), and patient engagement apps, enabling healthcare providers to deliver remote care and monitor patients in real-time. Similarly, in financial services, BaaS is helping institutions manage mobile banking, payment processing, and customer relationship management (CRM) systems, driving efficiency and improving customer experiences.

The gaming industry is another key driver of BaaS adoption, as developers leverage cloud-based backend services to handle multiplayer functionalities, user data storage, and in-app purchases, ensuring that gaming experiences are smooth and scalable.

Deployment Insights:

The Backend-as-a-Service Market is divided into public cloud, private cloud, and hybrid cloud deployment models. Public cloud BaaS dominates the market due to its cost-effectiveness, scalability, and ease of access. Businesses of all sizes are opting for public cloud BaaS platforms to quickly deploy applications without worrying about server infrastructure and maintenance.

Private cloud deployments, while less common, are critical for organizations with stringent security and compliance requirements, such as those in the financial services and government sectors. These companies prefer private cloud solutions to maintain full control over their backend infrastructure and ensure the highest levels of data privacy.

Hybrid cloud solutions, which combine the flexibility of public cloud with the security of private cloud, are gaining traction as businesses look for more customized and adaptable BaaS options. The hybrid model allows organizations to benefit from the scalability of the public cloud while keeping sensitive operations in-house.

Key Companies & Market Share Insights:

The Backend-as-a-Service Market is highly competitive, with several key players driving innovation and market expansion. Leading companies include Google LLC, Amazon Web Services (AWS), Microsoft Corporation, IBM Corporation, and Oracle Corporation. These tech giants dominate the market through their comprehensive cloud infrastructure offerings, which provide seamless BaaS integration for enterprises and developers.

Google Firebase, for instance, is a widely adopted BaaS platform that offers a full suite of backend services, including cloud storage, analytics, and real-time database management. Amazon Web Services (AWS) continues to strengthen its position with AWS Amplify, a BaaS offering designed for mobile and web apps that require real-time data synchronization and secure user authentication.

Recent Developments:

Google LLC recently enhanced its Firebase platform with new features focused on improving data security and app performance monitoring for developers.
Amazon Web Services (AWS) expanded its AWS Amplify platform to support AI-powered backend services, enabling developers to integrate machine learning models into their apps seamlessly.
Microsoft Corporation introduced new capabilities in its Azure App Services, streamlining the process for building and deploying apps on the cloud with enhanced backend management tools.
IBM Corporation is advancing its IBM Cloud platform with added support for hybrid cloud BaaS solutions, helping enterprises manage their backend operations across both public and private clouds.
Oracle Corporation continues to innovate in the BaaS space with new security-focused features for Oracle Cloud, targeting industries with high regulatory requirements, such as healthcare and finance.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

In-Counter Barcode Scanners Market Value to Grow by Almost US$ 4587.9 Million in 2032 | Future Market Insights, Inc.

The market for in-counter barcode scanners is anticipated to reach US$ 2,194.5 Million in 2022. The demand for in-counter barcode scanners is expected to grow at a CAGR of 7.7% between 2022 and 2032, reaching a total of about US$ 4,587.9 Million by 2032. This is due to factors such as the increasing penetration of e-commerce, the simplification of payment routes, streamlining of warehouse inventory, and growing presence in public distribution systems.

Due to the increase in the number of e-retailers in the market and the shift towards the digitalization of public distribution system, the In-counter barcode scanners market is growing rapidly. The In-counter barcode scanners market is rapidly growing in retail and warehousing industries.

The technological advantages and cutting-edge features of the in-counter barcode scanners are making them more popular in various industries. Also, the availability of innovative and customized products such as mobile computing devices are fueling the growth of in-counter barcode scanners market.

The advent of barcode technology has reduced the hurdles in the tracking and supply for the retailers in the market. In-counter barcode scanners technology has been consistently improved and made more efficient and as a result, now a days, most of the products come in the market has barcodes printed on it, which are scanned through barcode scanners.

Today, in-counter barcode scanners have become one of the best solution for recording and managing product information without making any major manual effort. In-counter barcode scanners are also used to make quick check-outs at cash counter, for easy and accurate account keeping and for better inventory control for manufacturers and retailers.

In-counter Barcode Scanners: Drivers and Challenges

Drivers

The emerging technologies in the public distribution system are the primary growth drivers of the In-counter barcode scanners market. Also, the Increasing requirement of Industries for remote solutions are also playing an important role in fueling In-counter barcode scanners market. Moreover, the growing number of multinational logistics service provides is one of the key factor which is driving the growth of In-counter barcode scanners market.

The In-counter barcode scanners helps to increase effectiveness and efficiency of operations by reducing error and by helping users to keep track of inventory which ultimately saves the time, and due to this factor, the demand for In-counter Barcode Scanners is increasing.

Challenges

The high cost of In-counter barcode scanners is one of the major challenges that is restraining the growth of In-counter barcode scanners market. Moreover, these in-counter barcode scanners are sometimes inconvenient to use as they fixed and it is difficult to move them from one place to another.

Key Players

The Prominent players in In-counter barcode scanners market are Honeywell International Inc., Zebra Technologies Corporation, Cognex Corporation, SATO Holdings Corporation, Toshiba TEC Corporation,Wasp Barcode Technologies, Datalogic S.P.A, Scandit AG and others.

In-counter Barcode Scanners: Regional Overview

On geographic basis, North America will be the largest market for In-counter barcode scanners market due to rapid adoption of advanced technologies in the public distribution system. APAC market will be the fastest growing In-counter barcode scanners market due to the presence of various key players in countries like China, India, Japan, and South Korea and rapid increase in number of e-retailers in this region. Latin America also offers potential growth opportunities in In-counter barcode scanners market due the rise in digital technologies in this region.

The report covers exhaustive analysis on

In-counter barcode scanners market Dynamics
In-counter barcode scanners market Segments
Supply & Demand Value Chain
In-counter barcode scanners Market Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
In-counter barcode scanners Market Drivers and Restraints

Key Segments Covered in the In-Counter Barcode Scanners Industry Report

In-Counter Barcode Scanners Market by Vertical:

Retail and Consumer Packaged Goods
Warehousing
Transport and Logistics

In-Counter Barcode Scanners Market by Region:

North America
Latin America
Europe
Asia Pacific
Middle East and Africa

Request a Sample of this Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-4972

About Future Market Insights (FMI)

Contact Us: